Calcitonin for the treatment of osteoporosis: dosage and dosing interval in Japan.
Yamauchi
Hirose
H
Clinical Development and Surveillance Center, Health Care Company, Asahi Kasei Corporation, 9-1 Kanda Mitoshirocho, Chiyoda-ku, Tokyo 101-8481, Japan.
Suzuki
Hiroaki
H
Orimo
Hajime
H
D000818:Animals; D001835:Body Weight; D001862:Bone Resorption / Q000188:drug therapy / Q000503:physiopathology; D002116:Calcitonin / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D007564:Japan; D010010:Osteoclasts / Q000166:cytology / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy* / Q000473:pathology
D002116:Calcitonin